INTA insider filing: 48,533 shares planned sale via Morgan Stanley ($2.17M)
Rhea-AI Filing Summary
Form 144 notice for Intapp, Inc. (INTA): The filer proposes to sell 48,533 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $2,169,425.10. The filing lists the securities' acquisition history: 30,000 shares from previously exercised stock options acquired and paid in cash on 12/18/2023, 12,302 performance stock units acquired on 08/20/2024, and 6,231 restricted stock units acquired on 08/20/2025. Recent dispositions by the same account include sales of 5,425 shares on 08/20/2025 for $228,150.20 and 2,604 shares on 08/21/2025 for $108,858.27. The filing includes the standard representation that the seller is unaware of undisclosed material adverse information and references Rule 10b5-1 procedures if applicable.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 filing to report an intended sale of executive-held shares; transaction size is small relative to total outstanding shares.
The notice documents a proposed open-market sale of 48,533 common shares via Morgan Stanley Smith Barney with an indicated aggregate market value of $2,169,425.10 and lists the acquisition sources and dates for those shares, including exercised options, performance stock units, and restricted stock units. The filer also reported two recent small dispositions on 08/20/2025 and 08/21/2025 totaling 8,029 shares and gross proceeds of $336, (approx) $336,? (Note: ensure parsing of numbers as provided) The filing is a compliance disclosure under Rule 144 and contains the standard attestations regarding material nonpublic information.
TL;DR: Compliance-focused disclosure indicating insider selling activity; documentation of grant types and dates is appropriate for transparency.
The form details the grant types (stock options, performance stock units, restricted stock units) and acquisition dates, which helps trace the insider's compensation realization. It includes the broker, intended sale date (09/08/2025), and the number of outstanding shares (82,120,030) for context. The filing contains the required representation about material adverse information and mentions Rule 10b5-1 where relevant, aligning with standard governance and disclosure practices.